Wells Fargo analyst Aaron Rakers maintains Micron Technology (NASDAQ:MU) with a Overweight and lowers the price target from $90 to $75.
Compass Therapeutics Announces $80M Private Placement
Compass Therapeutics, Inc. (NASDAQ:CMPX), ("Compass"), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced that it has entered